Active Entries
- 1: How Biden’s sanctions are funding Putin’s war against Ukraine
- 2: Девятый пикет Команды поддержки Украины у Белого Дома
- 3: Сливы от «Вашингтон пост» как очередная «стратегическая коммуникационная кампания»
- 4: Кто и как создал коронавирус
- 5: Эволюция позиции G7 в отношении войны
- 6: Об отсутствии стратегической цели коллективного Запада в войне
- 7: Уникальный дуэт. Михаил Веллер и Гари Табах
- 8: Последует ли расплата за войну?
- 9: Цели российских оппозиционных сил
- 10: A look inside the mind of Vladimir Putin
Style Credit
- Style: Neutral Good for Practicality by
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
timeasmymeasure
Expand Cut Tags
No cut tags
no subject
Date: 2020-06-18 03:40 pm (UTC)Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.
https://www.breitbart.com/economy/2020/04/07/fact-check-trump-does-not-own-stake-in-a-hydroxychloroquine-drugmaker/
Fact Check: Trump Does Not Own Stake in a Hydroxychloroquine Drugmaker
Trump’s most recent financial disclosure forms lists holdings in the Dodge & Cox International Fund valued between $1,001 and $15,000.
That means Trump holds a maximum stake in the mutual funds of $45,000, giving him an indirect interest in Sanofi of $1,485 at the most.
His “financial interest” in Sanofi, which has a market capitalization of nearly $58 billion, could be as low as $99.10.